Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

"FALCO" aims for cost-efficient glaucoma screening

Dear Sir or Madam,

Glaucoma is a treacherous eye disease: Without screening, it is often only noticed when the retina or the optic nerve is damaged. But the OCT devices that are required for screening are very expensive, limiting their availability. Read in our interview about project FALCO how researchers want to reduce the costs for these devices.

Enjoy reading!

Timo Roth
Editorial team MEDICA-tradefair.com

Table of Contents

Interview: "FALCO" for glaucoma screening
Newsletter Service
Image: Banner with the text: MEDICA Magazine – 365 days a year; Copyright: Messe Düsseldorf

Microelectrode array: hammock for brain organoids

LAB & DIAGNOSTICS

Novel microelectrode array system enables long-term cultivation and electrophysiological analyses of brain organoids.
read more
To top

FALCO project: low-cost glaucoma screening system

Interview – MED TECH & DEVICES

Image:An ophthalmologist looking at an OCT image together with the patient; Copyright: olgaseleznovaphoto
Glaucoma is wicked, because the disease often goes undetected until irreversible damage of the optic nerve has occurred. This makes regular eye exams even more important. Optical coherence tomography (OCT) is an imaging method that facilitates an early diagnosis of glaucoma. However, traditional OCT machines are very expensive. That’s why the FALCO project aims to develop a more cost-effective system.
Click here for the interview
FALCO project: Comprehensive glaucoma prevention thanks to low-cost screening system
Read all content from the experience world MED TECH & DEVICES in the MEDICA Magazine here
To top

Wound dressing reveals infection

DISPOSABLES

A nanocellulose wound dressing that can reveal early signs of infection without interfering with the healing process has been developed by researchers at Linköping University, Sweden.
read more
To top

Collaborative and sustainable - the DZHK's clinical research platform

DIGITAL HEALTH

At the German Center for Cardiovascular Research (DZHK), clinical study data and samples belong not to individual clinics but to a superordinate structure - the DZHK. The basis for this is the collaborative clinical research platform launched ten years ago, which makes data and samples from all DZHK studies uniformly recordable.
read more
To top

Computer-assisted procedure classifies Ataxia-related speech disturbances

DIGITAL HEALTH

Researchers at DZNE and the University Hospital Bonn, together with the Berlin-based company PeakProfiling GmbH, have developed a computer-assisted method that recognizes the severity of speech disturbances resulting from ataxia, a brain disease, with great accuracy.
read more
To top

AI-based method to replace chemical staining of tissue

DIGITAL HEALTH

Researchers have developed an artificial intelligence-based method for virtual staining of histopathological tissue samples as a part of the Nordic ABCAP consortium.
read more
To top

Plasma against precancerous skin lesions: EU funds international doctoral candidates network

MED TECH & DEVICES

Under the leadership of the Leibniz Institute for Plasma Science and Technology (INP), the international doctoral candidates network PlasmACT is investigating the use of medical gas plasma technology as a treatment method.
read more
To top

How electricity can heal wounds three times as fast

MED TECH & DEVICES

Using electric stimulation, researchers in a project at Chalmers University of Technology, Sweden, and the University of Freiburg, Germany, have developed a method that speeds up the healing process, making wounds heal three times faster.
read more
To top

Dutch digital health technology company LifeSense Group signs first strategic media investment agreement with SevenVentures to empower families in Germany

LifeSense Group BV

LifeSense Group B.V. (LSG), developer of Oopsie Heroes Plus (OH+), has signed a first strategic media investment agreement with SevenVentures, the leading German TV media investor, which is part...
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Bernhard J. Stempfle, Erhard Wienkamp

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook X LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.